Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Glioma Stories

2013-05-01 15:32:07

A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute. The researchers led a study of pediatric low-grade gliomas, samples of which were collected through an international consortium organized by brain tumor specialists at Dana-Farber/Children's Hospital Cancer Center. Their findings are being...

2013-04-17 15:56:49

"Current wisdom says that cells are closed entities that communicate through the secretion of soluble signalling molecules. Recent findings indicate that cells can exchange more complex information — whole packages of genetic material and signalling proteins. This is an entirely new conception of how cells communicate", says Dr Mattias Belting, Professor of Oncology at Lund University and senior consultant in oncology at SkÃ¥ne University Hospital, Lund, Sweden. Exosomes...

2013-04-15 13:03:20

The St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies The St. Jude Children's Research Hospital — Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the...

2013-04-14 12:21:35

The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies MEMPHIS, Tenn., April 14, 2013 /PRNewswire-USNewswire/ -- The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high...

2013-04-10 08:31:36

VANCOUVER, British Columbia and MENLO PARK, Calif., April 10, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor. The data are being presented at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. during a clinical poster session entitled, "A Phase...

2013-04-01 23:01:45

In a first-of-its-kind experiment using microvesicles generated from mesenchymal bone marrow cells (MSCs) to treat cancer, neurological researchers at Henry Ford Hospital have discovered a novel approach for treatment of tumors. Specifically, the research team found that introducing genetic material produced by MSCs significantly reduced a particularly resistant form of malignant brain tumor in living lab rats. Detroit, Michigan (PRWEB) April 01, 2013 DETROIT — In a first-of-its-kind...

2013-03-26 12:30:06

-- Genomic, Molecular Findings by CHOP Researchers Will Help Inform Personalized Medicine -- PHILADELPHIA, March 26, 2013 /PRNewswire-USNewswire/ -- Pediatric researchers, investigating the biology of brain tumors in children, are finding that crucial differences in how the same gene is mutated may call for different treatments. A new study offers glimpses into how scientists will be using the ongoing flood of gene-sequencing data to customize treatments based on very specific mutations...

2013-03-22 23:04:18

Louis and Phyllis Jacobs Honored for Commitment to Brain Tumor Patients and the ABTA Chicago, IL (PRWEB) March 22, 2013 The American Brain Tumor Association (ABTA) has named Louis and Phyllis Jacobs as the recipients of the 2013 Joel A. Gingras, Jr. Award. For the past 14 years, the Jacobs have supported brain tumor patients and families in their community, as well as supported the ABTA´s brain tumor research funding initiatives. The Joel A. Gingras, Jr. Award is given annually to an...

2013-03-07 08:29:18

Booke & Co. to Provide Investor Relations Counsel VANCOUVER, British Columbia and MENLO PARK, Calif., March 7, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the completion of a $10.5 million private placement. Charles Vista, LLC acted as the company's placement agent in the unit offering. Each unit consists of one share of common stock and one common stock purchase warrant. The maximum offering in the Private Placement consisted of...

2013-03-05 23:04:41

Scientists at Duke and Johns Hopkins found mutations in two genes that could become therapeutic targets in malignant glioma. Could this be the research breakthrough in the type of pediatric brain stem tumor that children must face? (PRWEB) March 05, 2013 The Rory David Deutsch Foundation wants you to know that there are many “heroes” in the fight to eradicate pediatric brain cancer. The children at the center of the battle lead the way. The scientists who put in long hours of...